Important notice regarding Rhopressa

Posted in Latest News on February 12, 2019.

The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa.



More Latest News

Brand Names not allowed on formulary.
July 23, 2019

The Board of Optometry met on July 18, 2019 in Orlando regarding adding Rocklatan to the formulary. Click here for more information on the formulary. Continue reading


Human Trafficking
July 10, 2019

Click here for new profession requirements and reporting procedures regarding Human Trafficking Continue reading